BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7810411)

  • 1. Is recombination of PRV vaccine strains a real problem?
    Visser N; Rziha HJ
    Acta Vet Hung; 1994; 42(2-3):183-93. PubMed ID: 7810411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of pseudorabies virus DNA and RNA in trigeminal ganglia and tonsil tissues of latently infected swine.
    Cheung AK
    Am J Vet Res; 1995 Jan; 56(1):45-50. PubMed ID: 7535023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aujeszky's disease virus strains with peculiar features.
    Motovski AD
    Acta Vet Hung; 1994; 42(2-3):213-6. PubMed ID: 7810415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of Aujeszky's disease virus recombinants from experimentally co-infected swine.
    Dangler CA; Henderson LM; Deaver RE; Bowman LA
    Acta Vet Hung; 1994; 42(2-3):209-12. PubMed ID: 7810414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential sites of virus latency associated with indigenous pseudorabies viruses in feral swine.
    Romero CH; Meade PN; Homer BL; Shultz JE; Lollis G
    J Wildl Dis; 2003 Jul; 39(3):567-75. PubMed ID: 14567217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes.
    Ferrari M; Mettenleiter TC; Romanelli MG; Cabassi E; Corradi A; Dal Mas N; Silini R
    J Comp Pathol; 2000; 123(2-3):152-63. PubMed ID: 11032669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
    McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
    Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Aujeszky's disease virus recombination in vitro under conditions of low multiplicity of infection.
    Dangler CA; Deaver RE; Kolodziej CM
    Acta Vet Hung; 1994; 42(2-3):205-8. PubMed ID: 7810413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
    Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
    Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine.
    Mengeling WL; Lager KM; Volz DM; Brockmeier SL
    Am J Vet Res; 1992 Nov; 53(11):2164-73. PubMed ID: 1466515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines.
    Weigel RM; Hahn EC; Scherba G
    Vet Microbiol; 2003 Mar; 92(1-2):19-24. PubMed ID: 12488067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pseudorabies viral DNA in tonsillar epithelial cells of latently infected pigs.
    Brown TT; Shin KO; Fuller FJ
    Am J Vet Res; 1995 May; 56(5):587-94. PubMed ID: 7661452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of changes in the short unique segment of pseudorabies virus BUK-TK900 (Suivac A) vaccine strain.
    Ficińska J; Bieńkowska-Szewczyk K; Jacobs L; Płucienniczak G; Płucienniczak A; Szewczyk B
    Arch Virol; 2003 Aug; 148(8):1593-612. PubMed ID: 12898333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombination of pseudorabies virus vaccine strains in swine.
    Henderson LM; Levings RL; Davis AJ; Sturtz DR
    Am J Vet Res; 1991 Jun; 52(6):820-5. PubMed ID: 1652903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.
    Delva JL; Van Waesberghe C; Van Den Broeck W; Lamote JA; Vereecke N; Theuns S; Couck L; Favoreel HW
    J Virol; 2022 Jun; 96(12):e0219921. PubMed ID: 35604216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.